[1]
S. Noorali and S. Haghighi, “Treatment of ampullary neuroendocrine tumor by Capecitabine (Xeloda®) and Temozolomide (Temodal®) ”, Gastroenterol Hepatol Bed Bench, vol. 14, no. 1, Jan. 2021.